174 related articles for article (PubMed ID: 26917959)
1. A blue fluorescent labeling technique utilizing micro- and nanoparticles for tracking in LIVE/DEAD® stained pathogenic biofilms of Staphylococcus aureus and Burkholderia cepacia.
Klinger-Strobel M; Ernst J; Lautenschläger C; Pletz MW; Fischer D; Makarewicz O
Int J Nanomedicine; 2016; 11():575-83. PubMed ID: 26917959
[TBL] [Abstract][Full Text] [Related]
2. Fluorescence and electron microscopy probes for cellular and tissue uptake of poly(D,L-lactide-co-glycolide) nanoparticles.
Panyam J; Sahoo SK; Prabha S; Bargar T; Labhasetwar V
Int J Pharm; 2003 Aug; 262(1-2):1-11. PubMed ID: 12927382
[TBL] [Abstract][Full Text] [Related]
3. [Transport of PLGA nanoparticles across Caco-2/HT29-MTX co-cultured cells].
Wen Z; Li G; Lin DH; Wang JT; Qin LF; Guo GP
Yao Xue Xue Bao; 2013 Dec; 48(12):1829-35. PubMed ID: 24689242
[TBL] [Abstract][Full Text] [Related]
4. Prevention of Oxidized Low Density Lipoprotein-Induced Endothelial Cell Injury by DA-PLGA-PEG-cRGD Nanoparticles Combined with Ultrasound.
Li Z; Huang H; Huang L; Du L; Sun Y; Duan Y
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28406431
[TBL] [Abstract][Full Text] [Related]
5. PEGylation strategies for active targeting of PLA/PLGA nanoparticles.
Betancourt T; Byrne JD; Sunaryo N; Crowder SW; Kadapakkam M; Patel S; Casciato S; Brannon-Peppas L
J Biomed Mater Res A; 2009 Oct; 91(1):263-76. PubMed ID: 18980197
[TBL] [Abstract][Full Text] [Related]
6. Observation of antibacterial effect of biodegradable polymeric nanoparticles on Staphylococcus epidermidis biofilm using FE-SEM with an ionic liquid.
Takahashi C; Ogawa N; Kawashima Y; Yamamoto H
Microscopy (Oxf); 2015 Jun; 64(3):169-80. PubMed ID: 25757698
[TBL] [Abstract][Full Text] [Related]
7. Long circulating chitosan/PEG blended PLGA nanoparticle for tumor drug delivery.
Parveen S; Sahoo SK
Eur J Pharmacol; 2011 Nov; 670(2-3):372-83. PubMed ID: 21951969
[TBL] [Abstract][Full Text] [Related]
8. PEG-functionalized microparticles selectively target inflamed mucosa in inflammatory bowel disease.
Lautenschläger C; Schmidt C; Lehr CM; Fischer D; Stallmach A
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):578-86. PubMed ID: 24084650
[TBL] [Abstract][Full Text] [Related]
9. Chitosan-modified poly(D,L-lactide-co-glycolide) nanospheres for plasmid DNA delivery and HBV gene-silencing.
Zeng P; Xu Y; Zeng C; Ren H; Peng M
Int J Pharm; 2011 Aug; 415(1-2):259-66. PubMed ID: 21645597
[TBL] [Abstract][Full Text] [Related]
10. [Transport of mPEG-PLGA nanoparticles across the rat nasal mucosa].
Wang JT; Lin DH; Qin LF; Wen Z; Guo GP
Yao Xue Xue Bao; 2013 May; 48(5):752-8. PubMed ID: 23888701
[TBL] [Abstract][Full Text] [Related]
11. Selective anticancer activity of hydroxyapatite/chitosan-poly(d,l)-lactide-co-glycolide particles loaded with an androstane-based cancer inhibitor.
Ignjatović NL; Penov-Gaši KM; Wu VM; Ajduković JJ; Kojić VV; Vasiljević-Radović D; Kuzmanović M; Uskoković V; Uskoković DP
Colloids Surf B Biointerfaces; 2016 Dec; 148():629-639. PubMed ID: 27694053
[TBL] [Abstract][Full Text] [Related]
12. Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile.
Rafiei P; Haddadi A
Int J Nanomedicine; 2017; 12():935-947. PubMed ID: 28184163
[TBL] [Abstract][Full Text] [Related]
13. 5-Fluorouracil-loaded PLA/PLGA PEG-PPG-PEG polymeric nanoparticles: formulation, in vitro characterization and cell culture studies.
Ocal H; Arica-Yegin B; Vural I; Goracinova K; Caliş S
Drug Dev Ind Pharm; 2014 Apr; 40(4):560-7. PubMed ID: 23596973
[TBL] [Abstract][Full Text] [Related]
14. Iontophoretic transdermal delivery using chitosan-coated PLGA nanoparticles for positively charged drugs.
Takeuchi I; Takeshita T; Suzuki T; Makino K
Colloids Surf B Biointerfaces; 2017 Dec; 160():520-526. PubMed ID: 29017147
[TBL] [Abstract][Full Text] [Related]
15. ISMN-loaded PLGA-PEG nanoparticles conjugated with anti-
Huang S; Ding P; Liu S; Li C; Zhang Y; Dong D; Zhao Y
Future Med Chem; 2021 Dec; 13(23):2033-2046. PubMed ID: 34612074
[No Abstract] [Full Text] [Related]
16. Design and Development of Bioceramic Based Functionalized PLGA Nanoparticles of Risedronate for Bone Targeting: In-vitro Characterization and Pharmacodynamic Evaluation.
Rawat P; Manglani K; Gupta S; Kalam A; Vohora D; Ahmad FJ; Talegaonkar S
Pharm Res; 2015 Oct; 32(10):3149-58. PubMed ID: 25840949
[TBL] [Abstract][Full Text] [Related]
17. Blow-spun chitosan/PEG/PLGA nanofibers as a novel tissue engineering scaffold with antibacterial properties.
Bienek DR; Hoffman KM; Tutak W
J Mater Sci Mater Med; 2016 Sep; 27(9):146. PubMed ID: 27568217
[TBL] [Abstract][Full Text] [Related]
18. Imaging of intracellular behavior of polymeric nanoparticles in Staphylococcus epidermidis biofilms by slit-scanning confocal Raman microscopy and scanning electron microscopy with energy-dispersive X-ray spectroscopy.
Takahashi C; Ueno K; Aoyama J; Adachi M; Yamamoto H
Mater Sci Eng C Mater Biol Appl; 2017 Jul; 76():1066-1074. PubMed ID: 28482470
[TBL] [Abstract][Full Text] [Related]
19. Effect of microfluidization parameters on the physical properties of PEG-PLGA nanoparticles prepared using high pressure microfluidization.
Sani SN; Das NG; Das SK
J Microencapsul; 2009 Sep; 26(6):556-61. PubMed ID: 18946802
[TBL] [Abstract][Full Text] [Related]
20. Polyester-based particles to overcome the obstacles of mucus and biofilms in the lung for tobramycin application under static and dynamic fluidic conditions.
Ernst J; Klinger-Strobel M; Arnold K; Thamm J; Hartung A; Pletz MW; Makarewicz O; Fischer D
Eur J Pharm Biopharm; 2018 Oct; 131():120-129. PubMed ID: 30063969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]